US FDA's risk communication advisory panel to meet
This article was originally published in Scrip
Executive Summary
A US FDAadvisory panel will meet on August 14th-15th to discuss the scientific basis for translating principles of risk communication into practice in situations of emerging and uncertain risk. This will be the third meeting of the new risk communication advisory committee; it previously discussed the agency's risk communication programmes and direct-to-consumer advertising.